OCT4 expression mediates partial cardiomyocyte reprogramming of mesenchymal stromal cells

Area of Science:

• Stem Cell Biology
• Cardiovascular Research
• Epigenetics

Background:

• Mesenchymal stem/stromal cells (MSCs) are utilized in cell therapies for cardiac repair.
• Understanding mechanisms of MSC cardiac differentiation is crucial for improving regenerative potential.
• The role of pluripotency factors like OCT4 in MSC cardiac lineage activation is largely unknown.

Purpose of the Study:

• To investigate the involvement of the pluripotency transcription factor OCT4 in activating cardiac lineage programs within MSCs.
• To elucidate the regulatory mechanisms, including epigenetic control, of OCT4 during MSC cardiac differentiation.

Main Methods:

• Co-culture of bone marrow-derived MSCs from GFP transgenic mice with rat embryonic cardiomyocytes.
• Analysis of cardiac-specific gene expression (Nkx2.5, ANF, α-cardiac actin) in MSCs.
• Flow cytometry and OCT4 promoter methylation analysis to assess OCT4 expression and regulation.
• siRNA-mediated OCT4 silencing in MSCs to evaluate its functional impact on cardiac differentiation.

Main Results:

• Co-cultured MSCs expressed cardiac genes and showed partial differentiation (7.6% GFP+ cells), retaining a stromal phenotype.
• Global OCT4 expression increased in co-cultured MSCs, with OCT4 promoter methylation significantly higher in differentiated cells.
• OCT4 silencing via siRNA drastically reduced cardiac marker expression in MSCs (GFP+ cells <1%).

Conclusions:

• OCT4 plays a critical role in the partial cardiomyocyte reprogramming of MSCs.
• Epigenetic mechanisms, specifically OCT4 promoter methylation, regulate OCT4 expression during MSC cardiac differentiation.
• This study reveals a novel mechanism involving OCT4 and cardiac microenvironment crosstalk in MSC multipotency and cardiac regeneration.